Figure S7 from Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma
posted on 2023-07-21, 17:40authored byMoon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen, Dipabarna Bhattacharya, Petrus Järvinen, Sara Tornberg, Harry Nísen, Tuomas Mirtti, Ilona Uski, Anita Kumari, Karita Peltonen, Arianna Draghi, Marco Donia, Anna Kreutzman, Satu Mustjoki
Figure S7 shows analyses of the co-culture assays involving CD107a/b, IFN-y,TNF-a and GzB expressions.
Funding
Punainen Risti Veripalvelu (Finnish Red Cross Blood Service)
Signe ja Ane Gyllenbergin Säätiö (Signe and Ane Gyllenberg Foundation)
Relander Foundation (The Relander Foundation)
State funding university-level health research in Finland
History
ARTICLE ABSTRACT
TILs are a heterogenous group of immune cells that recognize and attack the tumor, thus are utilized in various clinical trials. In our study, we explored the TILs in patients with kidney cancer by expanding the TILs using a clinical-grade protocol, as well as observed their characteristics and ability to recognize the tumor using in-depth experimental and computational tools.